Tickertape - Financial freedom begins here

IDFC First Bank has allotted 20,16,620 equity shares under ESOS on 12 March 2026. Post allotment of aforesaid equity shares, the issued and paid-up equity share capital of the Bank stands increased to Rs 86,01,20,86,600/- comprising of 8,60,12,08,660 equity shares of Rs 10/- each fully paid-up.Powered by Capital Market - Live

ICICI Lombard General Insurance Company has allotted 91,272 equity shares under ESOS on 12 March 2026. Powered by Capital Market - Live

AU Small Finance Bank has allotted 1,33,465 equity shares under ESOP on 12 March 2026. The paid-up equity share capital of the Bank will accordingly increase from Rs. 7,48,09,10,520 to Rs. 7,48,22,45,170. Powered by Capital Market - Live

Bikaji Foods International has allotted 1,43,690 equity shares under ESOS on 12 March 2026. Consequent to the above-mentioned allotment, the paid-up share capital of the Company stands increased to Rs 25,07,36,400 consisting of 25,07,36,400 equity shares having face value of Rs 1.Powered by Capital Market - Live

Ideaforge Technology has allotted 756 equity shares under ESOP on 12 March 2026. Post allotment, the paid-up capital of the Company stands increased from Rs. 43,27,51,720/- comprising of 4,32,75,172 equity shares of Rs. 10/- each fully paid-up to Rs. 43,27,59,280 comprising of 4,32,75,928 equity shares of Rs. 10/- each fully paid-up.Powered by Capital Market - Live

The board of Max Financial Services at its meeting held 12 March 2026 has approved raising of fund by way of a qualified institutional placement for an amount not exceeding Rs 2,000 crore.  The proposed utilization of fund raise is primarily to meet the funding requirements of its material subsidiary company, viz., Axis Max Life Insurance, for supporting its business growth and expansion plans and balance for general corporate purposes. The board also approved increase in authorised share capital of the company from Rs 70 crore to Rs 75 crore. Powered by Capital Market - Live

WeWork India Management announced that CRISIL Ratings has assigned its bank facilities, totaling Rs. 800 crore, a rating of CRISIL A+/Stable for long-term facilities and CRISIL A1 for short-term facilities. Powered by Capital Market - Live

Sigma Advanced System has completed the divestment of its entire 36.52% equity stake in Extrovis AG, a Switzerland-based pharmaceutical company. The transaction has generated $15 million (approximately Rs 137.61 crore), providing the company with additional financial flexibility as it accelerates the expansion of its aerospace and defence business. The divestment forms part of Sigma's ongoing portfolio rationalisation strategy, and the company has transformed into a pureplay aerospace and defence platform. By exiting a non-core pharmaceutical investment, Sigma is freeing up capital that can now be deployed toward strengthening manufacturing capabilities, pursuing strategic acquisitions, and expanding its presence across global defence and aerospace supply chains.Powered by Capital Market - Live

Aurum Proptech today announced that its Board of Directors has approved the sale of Buildings Q5 and Q6 at Millennium Business Park, Navi Mumbai, for a total consideration of Rs 112 crore, approximately 15% above the valuation provided by the valuers. The transaction forms part of Aurum PropTech's broader strategic shift toward AI-driven PropTech platforms, with the company committing significant capital toward building advanced artificial intelligence capabilities across the real estate ecosystem. The proceeds from the transaction will further strengthen Aurum's growing AI investment pool and support the accelerated development of intelligent digital infrastructure for the real estate sector. The assets have a approximate book value of Rs 27 crore, and the transaction will generate a substantial profit, thereby enhancing the Group's profitability metrics and strengthening its balance sheet. Following the completion of the transaction, Aurum PropTech is expected to become debt-free, as the sale proceeds will be utilized to prepay Lease Rental Discounting facility (LRD) of Rs 56 crore. Powered by Capital Market - Live

The Board of Jagsonpal Pharmaceuticals at its meeting held on 12 March 2026 approved a proposal to buyback up to 16,00,000 fully paid-up equity shares of the company at a price of Rs 250 per equity shares (a premium of through Tender Offer method, subject to shareholders approval. This represents 2.4% of the total equity shares of the Company and 7.3% of the non-promoter shareholding of the company. The proposed buyback will be undertaken for an aggregate amount not exceeding Rs 40 crore, representing ~18.4% of the company's total paid-up equity share capital and free reserves based on the latest audited financial statements as of 31 March 2025. Powered by Capital Market - Live